Doxorubicin liposome Intravenous and Lanreotide Subcutaneous
Determining the interaction of Doxorubicin liposome Intravenous and Lanreotide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: doxorubicin liposomal
Brand name: Doxil, Lipodox, Lipodox 50
Synonyms: Doxorubicin liposomal, DOXOrubicin (Liposomal)
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Doxorubicin liposome Intravenous-Lansoprazole
- Doxorubicin liposome Intravenous-Lansoprazole Delayed-Release Capsules
- Doxorubicin liposome Intravenous-Lansoprazole Orally Disintegrating Tablets
- Doxorubicin liposome Intravenous-Lansoprazole, Amoxicillin, and Clarithromycin
- Doxorubicin liposome Intravenous-Lanthanum
- Doxorubicin liposome Intravenous-Lanthanum carbonate
- Lanreotide Subcutaneous-Doxy 100
- Lanreotide Subcutaneous-Doxycycline
- Lanreotide Subcutaneous-Doxycycline Calcium
- Lanreotide Subcutaneous-Doxycycline Capsules (Rosacea)
- Lanreotide Subcutaneous-Doxycycline Capsules with Omega-3 and Vitamin E Capsules
- Lanreotide Subcutaneous-Doxycycline Delayed Release Capsule